EMAIL DETAILS

Eric D. Schwerin
eschwerin@rosemontseneca.com

Sent from my iPhone

Begin forwarded message:

*From:* Linda Powers <lpowers@nwbio.com>
*Date:* May 5, 2016 at 3:04:42 PM EDT
*To:* Eric Schwerin <eschwerin@rosemontseneca.com>
*Cc:* Les Goldman <lgoldman@nwbio.com>
*Subject:* *RE: Follow Up*

Hi Eric:


Thanks so much for following up while Hunter is on the road… No, nothing
that we wanted to ask Hunter to do at the moment. Please convey an extra
big Thank You to Hunter for checking about that from the road. We really
appreciate it!!


What we wanted to connect with Hunter about are several significant new
developments, some very good, some not so much…


One of the updates is that we (Les) met with Senator Murray’s senior FDA
staffer and provided the key info about the rogue committee, and Senator
Murray’s staff “got it” right away and expressed a significant interest in
helping. So, that was a wonderful response. We also have connected with
Senator Alexander’s senior FDA staff but had to wait on proceeding with
that meeting due to some major regulatory filings that we had to
concentrate on.


We are, indeed, still planning to get the sanitized and shortened version
of the paper to you and Hunter – it just got overtaken by events during the
last couple of weeks after the Hill staff meetings, due to some new
developments that are part of the updates we’d like to discuss.


We also have several other updates… whenever feasible, it would be great to
discuss in a call.


We have not yet reached out to Chris, as we are not yet able to pursue the
change of counsel for the existing cases, and also not able to undertake a
new case…. also due to some new developments.


Let’s connect whenever feasible.


Kind regards,


Linda


*From:* Eric Schwerin [mailto:eschwerin@rosemontseneca.com
<eschwerin@rosemontseneca.com>]
*Sent:* Thursday, May 05, 2016 2:14 PM
*To:* Linda Powers
*Subject:* Follow Up


Linda-


Hunter is traveling but asked me to follow up with you and make sure that
there is nothing you were looking for Hunter to do at the moment. I think
when we touched base you were working on finalizing that one-pager and
Hunter had volunteered to get it to Senator Murray but we never heard more
from you. I assume it got over taken by other events?


I know Hunter has had a few talks with Dennis but I just wanted to make
sure I didn’t drop the ball on anything here.


Also, I understand from Chris Boies that you were supposed to talk with him
but had to move the call due to an emergency. Are you still interested in
following up with Chris?


Thanks,


Eric


Eric D. Schwerin

Rosemont Seneca Advisors, LLC

1010 Wisconsin Ave., NW

Suite 705

Washington, DC 20007

(202) 333-1880

eschwerin@rosemontseneca.com <x-msg://59/eschwerin@obblaw.com>

*P* *Consider the environment before printing this email.*


On Mar 30, 2016, at 5:18 PM, Hunter Biden <hbiden@rosemontseneca.com> wrote:


Linda,

Thank you for this. I'm cc'ing my business partner, Eric Schwerin, who can
also give some input/suggested edits. In regards to the sensitivity of
this document, you may want to provide us with a sanitized version. Sen.
Murray is not in town right now so we won't be able to physically give it
to her, plus she will likely turn around and give it to her staff anyways.
In the interest of time, we were planning to approach her chief of staff
with this, so if you would prefer that we share a sanitized version with
him, please send me that.


Thanks for keeping me posted about the FDA reply.


Best,

Hunter


On Tue, Mar 29, 2016 at 10:58 PM, Linda Powers <lpowers@nwbio.com> wrote:

Dear Hunter:


Attached is a shortened version. As you will see, we have cut about 2/3 of
a page of text and eliminated a number of the secondary points from the
story. It is now less than 2 pages, but not quite down to 1-1/2 pages.
Please take another look and let us know if this will do. If you think it
still needs to be shorter, it would be great if you could suggest (with
fresh eyes) what to cut.


IMPORTANT NOTE: This paper tells the true and unvarnished facts. As
such, it is ultra ultra sensitive. If this paper were to fall into the
wrong hands, it could lead to severe repercussions for NW Bio. So, please
only give the paper in PDF format and please only to Patty herself – not
her staff. If that’s not possible, and you have to give it to her staff,
please tell us before you give it to them, and we will make a sanitized
version.


FYI, we submitted our reply letter to FDA today, requesting a formal
in-person meeting with us and our independent experts. It will be
interesting to see whether FDA grants us the meeting (which is absolutely
the normal thing to do)…. or refuses to meet with us, as the DMC did last
summer….


Thanks again for your help. Kind regards,


Linda


*From:* Linda Powers
*Sent:* Tuesday, March 29, 2016 4:09 PM
*To:* 'Hunter Biden'
*Cc:* Les Goldman
*Subject:* RE: NW Bio completed 1-pager...


Dear Hunter:


Thanks very much for your feedback. Appreciate it. We literally just
filed our reply letter with FDA (at 3:58 pm!... ahead of 4 pm cutoff). So,
now we can turn back to this memo and take another crack at shortening it.
Do you have any suggestions about what to cross out? We will aim to get a
reduced version back to you this evening.


Kind regards,


Linda


*From:* Hunter Biden [mailto:hbiden@rosemontseneca.com
<hbiden@rosemontseneca.com>]
*Sent:* Tuesday, March 29, 2016 3:40 PM
*To:* Linda Powers
*Cc:* Les Goldman
*Subject:* Re: NW Bio completed 1-pager...


Dear Linda,

Thank you for putting this together. I think it is really important to get
this down to no more than 1 1/2 pages. My suggestion would be to stick with
the key issue and request for this 1-pager as you will have other
opportunities to expand on the background later down the road. Let me know
when you have an idea of timing for turning this around. Thanks again.


Best,

Hunter


On Mon, Mar 28, 2016 at 11:41 PM, Linda Powers <lpowers@nwbio.com> wrote:

Dear Hunter:


Attached is the completed draft of the “1-pager”…. which is actually 2
pages. We really struggled to make it as tight as possible, but ther is so
much key information that we just did not get it into 1 page. If you read
it with fresh eyes and see how it can be cut down from 2 pages, suggested
edits to do so would be welcome.


If you think it’s OK at a length of 2 pages, then let’s put our heads
together about how best to send it out the door. Thanks!


Kind regards,


Linda


*From:* Linda Powers
*Sent:* Monday, March 28, 2016 6:17 PM
*To:* 'hbiden@rosemontseneca.com'
*Cc:* Les Goldman
*Subject:* RE: Quick update: we're working on the 1-pager


Hi Hunter:


We have been working all day with the statisticians in regard to the
updated data (still on a blinded basis). We just got off a conf call with
them, receiving the data and…. it is excellent! Would you like to hear it
(under our CDA)? We can give you a quick call. [?]


Attached is the mostly-but-not-completely finished 1-pager that I drafted
during the weekend. It was devilishly difficult to make it tight enough.
Comments welcome. I’m about to turn back to finishing the last 2 points as
noted in the paper.


We have not reached out to Chris yet but plan to do so first thing in the
morning, now that we have the update data and we know that it’s good.


Kind regards,


Linda


*From:* hbiden@rosemontseneca.com [mailto:hbiden@rosemontseneca.com
<hbiden@rosemontseneca.com>]
*Sent:* Monday, March 28, 2016 5:43 PM
*To:* Linda Powers
*Cc:* Les Goldman
*Subject:* Re: Quick update: we're working on the 1-pager


Any progress on this? Have you reached out to Chris Boies?

RHB

202-333-1880


On Mar 25, 2016, at 12:18 PM, Linda Powers <lpowers@nwbio.com> wrote:

Hi Hunter:


Just a quick update to let you know that we’re working on the 1-pager.
Last night and this morning, we’ve been working intensively on obtaining
some key info for the 1-pager, as well as tied up in calls with our Board
members. We hope to have the 1-pager to you in the next hour or so.


Thanks SO much for your help! We are really grateful.


Kind regards,


Linda


--

R. Hunter Biden

Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880


--

R. Hunter Biden

Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-188